Islet Management’s Privia Health PRVA Stock Holding History

Islet Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-350,000	Closed	-$9.05M	–	195
2021 Q4	$9.05M	Buy	+350,000	New	+$8.72M	0.25%	115

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Islet Management's PRVA Position: Q1 2022 in Review

Islet Management sold out of Privia Health (PRVA) in Q1 2022, closing a stake of 350,000 shares — an estimated $9.05M sold.

Islet Management first reported a position in PRVA in Q4 2021 and held it in 1 quarter. The position peaked at $9.05M in Q4 2021. 146 funds tracked by Wall St. Rank hold PRVA as of Q1 2022.

Islet Management reported no remaining Privia Health position as of Q1 2022 after selling out during the quarter.
Islet Management sold 350,000 Privia Health shares in Q1 2022, an estimated $9.05M.
Islet Management first reported a position in Privia Health in Q4 2021 and held it in 1 quarter.
Islet Management's Privia Health position peaked at $9.05M in Q4 2021.
146 funds tracked by Wall St. Rank held Privia Health as of Q1 2022.

Based on Islet Management's 13F filing for Q1 2022, filed 13 May 2022.